Related content

Chronic myelomonocytic leukemia

By Bennett John  

Current Treatment Options in Oncology, Vol. 3, Iss. 3, 2002-06 ,pp. : 221-223

Springer Publishing Company

Access to resources Recommend Favorite

Brain pseudo-tumoral inflammatory lesion associated with chronic myelomonocytic leukemia

By Joubert Bastien  

Journal of Neuro-Oncology, Vol. 113, Iss. 1, 2013-05 ,pp. : 149-150

Springer Publishing Company

Access to resources Recommend Favorite

Conversion of childhood acute lymphocytic leukemia (L2) with a double t(12;21) to juvenile myelomonocytic leukemia with a novel t(4;11)(p12;q23): a cytogenetic, morphologic, and immunophenotypic study

By Manor E.   Shubinsky G.   Moser A.M.   Gurevitch D.   Chatach F.   Yermiahu T.   Kapelushnik J.  

Cancer Genetics and Cytogenetics, Vol. 147, Iss. 2, 2003-12 ,pp. : 110-114

Elsevier

Access to resources Recommend Favorite

Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case report

By  

Oncology Letters, Vol. 9, Iss. 3, 2015-01 ,pp. : 1217-1220

Spandidos Publications

Access to resources Recommend Favorite

Chronic myelomonocytic leukemia with p190 BCR-ABL rearrangement mimicking advanced liver disease at presentation

By Alagiozian-Angelova Victoria   Kadkol Shrihari   Lindgren Valerie   Peace David   Gaitonde Sujata  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 554-556

Informa Healthcare

Access to resources Recommend Favorite